Benjamin C Blount

Prof. Benjamin C Blount

Centers for Disease Control and Prevention
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
BBBenjamin C Blount
Benjamin C Blount
MKMateusz P. Karwowski
Mateusz P. Karwowski
PSPeter G. Shields
Peter G. Shields
MMMaria Morel-Espinosa
Maria Morel-Espinosa
LVLiza Valentin-Blasini
Liza Valentin-Blasini
JPJames L. Pirkle
James L. Pirkle
The causative agents for the current national outbreak of electronic-cigarette, or vaping, product use–associated lung injury (EVALI) have not been established. Detection of toxicants in bronchoalveolar-lavage (BAL) fluid from patients with EVALI can provide direct information on exposure within the lung. BAL fluids were collected from 51 patients with EVALI in 16 states and from 99 healthy participants who were part of an ongoing study of smoking involving nonsmokers, exclusive users of e-cigarettes or vaping products, and exclusive cigarette smokers that was initiated in 2015. Using the BAL fluid, we performed isotope dilution mass spectrometry to measure several priority toxicants: vitamin E acetate, plant oils, medium-chain triglyceride oil, coconut oil, petroleum distillates, and diluent terpenes. State and local health departments assigned EVALI case status as confirmed for 25 patients and as probable for 26 patients. Vitamin E acetate was identified in BAL fluid obtained from 48 of 51 case patients (94%) in 16 states but not in such fluid obtained from the healthy comparator group. No other priority toxicants were found in BAL fluid from the case patients or the comparator group, except for coconut oil and limonene, which were found in 1 patient each. Among the case patients for whom laboratory or epidemiologic data were available, 47 of 50 (94%) had detectable tetrahydrocannabinol (THC) or its metabolites in BAL fluid or had reported vaping THC products in the 90 days before the onset of illness. Nicotine or its metabolites were detected in 30 of 47 of the case patients (64%). Vitamin E acetate was associated with EVALI in a convenience sample of 51 patients in 16 states across the United States. (Funded by the National Cancer Institute and others.)

1 December 2006 in Environmental Health Perspectives
Verified
Journal Article
Open access
BBBenjamin C Blount
Benjamin C Blount
JPJames L. Pirkle
James L. Pirkle
JOJohn D. Osterloh
John D. Osterloh
LVLiza Valentin-Blasini
Liza Valentin-Blasini
KCKathleen L. Caldwell
Kathleen L. Caldwell
Perchlorate is commonly found in the environment and known to inhibit thyroid function at high doses. Assessing the potential effect of low-level exposure to perchlorate on thyroid function is an area of ongoing research.We evaluated the potential relationship ...

15 November 2019 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Closed access
BBBenjamin C Blount
Benjamin C Blount
MKMateusz P Karwowski
Mateusz P Karwowski
MMMaria Morel-Espinosa
Maria Morel-Espinosa
JRJon Rees
Jon Rees
CSConnie Sosnoff
Connie Sosnoff
JPJames L Pirkle
James L Pirkle
Bronchoscopy and bronchoalveolar lavage can be part of the clinical and diagnostic workup of e-cigarette, or vaping, product use–associated lung injury patients.

18 October 2006 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Closed access
BBBenjamin C Blount
Benjamin C Blount
LVLiza Valentin-Blasini
Liza Valentin-Blasini
JOJohn D Osterloh
John D Osterloh
JMJoshua P Mauldin
Joshua P Mauldin
JPJames L Pirkle
James L Pirkle

EBElizabeth Boyle
Elizabeth Boyle
SVSusan M. Viet
Susan M. Viet
DWDavid J. Wright
David J. Wright
LMLori Merrill
Lori Merrill
KAK. Udeni Alwis
K. Udeni Alwis
MDMichael Dellarco
Michael Dellarco
Epidemiologic studies can measure exposure to volatile organic compounds (VOCs) using environmental samples, biomarkers, questionnaires, or observations. These different exposure assessment approaches each have advantages and disadvantages; thus, evaluating relationships is an important consideration. In the National Children’s Vanguard Study from 2009 to 2010, participants completed questionnaires and data collectors observed VOC exposure sources and collected urine samples from 488 third trimester pregnant women at in-person study visits. From urine, we simultaneously quantified 28 VOC metabolites of exposure to acrolein, acrylamide, acrylonitrile, benzene, 1-bromopropane, 1,3-butadiene, carbon disulfide, crotonaldehyde, cyanide, N,N-dimethylformamide, ethylbenzene, ethylene oxide, propylene oxide, styrene, tetrachloroethylene, toluene, trichloroethylene, vinyl chloride, and xylene exposures using ultra high performance liquid chromatography coupled with an electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS) method. Urinary thiocyanate was measured using an ion chromatography coupled with an electrospray ionization tandem mass spectrometry method (IC-ESI/MSMS). We modeled the relationship between urinary VOC metabolite concentrations and sources of VOC exposure. Sources of exposure were assessed by participant report via questionnaire (use of air fresheners, aerosols, paint or varnish, organic solvents, and passive/active smoking) and by observations by a trained data collector (presence of scented products in homes). We found several significant (p < 0.01) relationships between the urinary metabolites of VOCs and sources of VOC exposure. Smoking was positively associated with metabolites of the tobacco constituents acrolein, acrylamide, acrylonitrile, 1,3-butadiene, crotonaldehyde, cyanide, ethylene oxide, N,N-dimethylformamide, propylene oxide, styrene, and xylene. Study location was negatively associated with the toluene metabolite N-acetyl-S-(benzyl)-l-cysteine (BMA), and paint use was positively associated with the xylene metabolites 2-methylhippuric acid (2MHA) and 3-Methylhippuric acid & 4-methylhippuric acid (3MHA + 4MHA). A near-significant (p = 0.06) relationship was observed between acrylamide metabolites and observation of incense.

GAGabriella M. Anic
Gabriella M. Anic
BRBrian Rostron
Brian Rostron
HHHoda T. Hammad
Hoda T. Hammad
DBDana M. van Bemmel
Dana M. van Bemmel
AVArseima Y. Del Valle-Pinero
Arseima Y. Del Valle-Pinero
CCCindy Chang
Cindy Chang
Limited data are available for how biomarkers of tobacco exposure (BOE) change when cigarette smokers transition to using electronic nicotine delivery systems (ENDS). Using biomarker data from Waves 1 (2013–2014) and 2 (2014–2015) of the PATH Study, we examined how mean BOE concentrations, including metabolites of nicotine, tobacco-specific nitrosamines (TSNA), polycyclic aromatic hydrocarbons (PAH), and volatile organic compounds (VOC) and metals, changed when 2475 adult smokers transitioned to using ENDS or quit tobacco products. Exclusive smokers who transitioned to dual use had a significant decrease in NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol), but not nicotine metabolites, most PAHs, metals, or VOCs. Exclusive smokers who became dual users had significant reductions in total nicotine equivalents, NNAL, and 2CyEMA (acrylonitrile metabolite), but only in those who reduced cigarettes per day (CPD) by >=50%. Smokers who transitioned to exclusive ENDS use had significant reductions in most TSNAs, PAHs, and VOCs; however, nicotine metabolites did not decrease in dual users who became exclusive ENDS users. Smokers who quit tobacco use had significant decreases in nicotine metabolites, all TSNAs, most PAHs, and most VOCs. Cigarette smokers who became dual users did not experience significant reductions in most BOEs. Reductions were impacted by changes in CPD. However, transitioning from smoking to no tobacco or exclusive ENDS use was associated with reduced exposure to most BOEs measured. Future analyses could incorporate additional waves of PATH data and examine changes in biomarker exposure by ENDS device type and CPD.